Tapewire

Nasdaq · USD

BBNX

Beta Bionics, Inc.

Export transactions ↓
Tapewire entity
2350
SEC CIK
0001674632
Parsed reports
115

Last 12 months

Inside the activity.

0 purchase rows · 49 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 2025010
Jan 202604
Feb 202600
Mar 202606
Apr 202600
May 202603
Jun 2026013
Jul 202600
Aug 202600
Sep 2026012
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2025 Filed Mar 3, 2025 22:45 UTC
Hopman MarkChief Commercial Officer
GrantCommon Stock 35,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-006234 · form4-03032025_050311.xml · nonDerivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 22:45 UTC
Mensinger MikeChief Product Officer
GrantEmployee Stock Option (right to buy) · Derivative 52,000 $0.00 Strike: $19.91 $0.00
Disclosure

SEC source: 0001415889-25-006232 · form4-03032025_050306.xml · derivative · entry 2

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,000

Underlying: Common Stock · 52,000 shares

Expires 2035-02-26

F2 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 22:45 UTC
Mensinger MikeChief Product Officer
GrantCommon Stock 35,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-006232 · form4-03032025_050306.xml · nonDerivative · entry 1

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,019

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 22:45 UTC
Feider StephenChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 71,000 $0.00 Strike: $19.91 $0.00
Disclosure

SEC source: 0001415889-25-006231 · form4-03032025_050304.xml · derivative · entry 2

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,000

Underlying: Common Stock · 71,000 shares

Expires 2035-02-26

F2 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 22:45 UTC
Feider StephenChief Financial Officer
GrantCommon Stock 47,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-006231 · form4-03032025_050304.xml · nonDerivative · entry 1

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,000

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 22:45 UTC
Saint SeanDirector · President & CEO
GrantEmployee Stock Option (right to buy) · Derivative 163,000 $0.00 Strike: $19.91 $0.00
Disclosure

SEC source: 0001415889-25-006230 · form4-03032025_050301.xml · derivative · entry 2

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,000

Underlying: Common Stock · 163,000 shares

Expires 2035-02-26

F2 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 22:45 UTC
Saint SeanDirector · President & CEO
GrantCommon Stock 108,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-006230 · form4-03032025_050301.xml · nonDerivative · entry 1

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,000

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC GrantDirector Stock Option (right to buy) · Derivative 9,137 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001415889-25-002821 · form4-02032025_080215.xml · derivative · entry 1

Palasis Maria · CIK 0001810701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,137

Underlying: Common Stock · 9,137 shares

Expires 2033-01-24

F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from August 15, 2022.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 16:49 UTC ConversionSeries E Preferred Stock · Derivative 2,901,599 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-012403 · ownership.xml · derivative · entry 3

Wellington Hadley Harbor Aggregator IV, L.P. · CIK 0002053997 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,901,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Immediately prior to the closing of the initial public offering, each share of Series E Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Immediately prior to the closing of the initial public offering, each share of Series E Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Immediately prior to the closing of the initial public offering, each share of Series E Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 16:49 UTC PurchaseCommon Stock 1,000,000 $17.00 $17,000,000.00
Disclosure

SEC source: 0000950170-25-012403 · ownership.xml · nonDerivative · entry 2

Wellington Hadley Harbor Aggregator IV, L.P. · CIK 0002053997 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,901,599

F2 · shares: Shares acquired in a private placement pursuant to the terms of a Common Stock Purchase Agreement dated January 21, 2025.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 16:49 UTC ConversionCommon Stock 2,901,599 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-012403 · ownership.xml · nonDerivative · entry 1

Wellington Hadley Harbor Aggregator IV, L.P. · CIK 0002053997 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,901,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Immediately prior to the closing of the initial public offering, each share of Series E Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Russell Steven JonChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 90,637 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001415889-25-002823 · form4-02032025_080220.xml · derivative · entry 3

Russell Steven Jon · CIK 0002051384 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,637

Underlying: Common Stock · 90,637 shares

Expires 2035-01-28

F4 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Russell Steven JonChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 53,584 $0.00 Strike: $5.10 $0.00
Disclosure

SEC source: 0001415889-25-002823 · form4-02032025_080220.xml · derivative · entry 2

Russell Steven Jon · CIK 0002051384 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,584

Underlying: Common Stock · 53,584 shares

Expires 2033-09-13

F3 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Russell Steven JonChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 81,217 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001415889-25-002823 · form4-02032025_080220.xml · derivative · entry 1

Russell Steven Jon · CIK 0002051384 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,217

Underlying: Common Stock · 81,217 shares

Expires 2032-12-14

F1 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after November 14, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Saint SeanDirector · President & CEO
GrantEmployee Stock Option (right to buy) · Derivative 467,944 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001415889-25-002822 · form4-02032025_080218.xml · derivative · entry 5

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 467,944

Underlying: Common Stock · 467,944 shares

Expires 2035-01-28

F6 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Saint SeanDirector · President & CEO
GrantEmployee Stock Option (right to buy) · Derivative 54,911 $0.00 Strike: $5.10 $0.00
Disclosure

SEC source: 0001415889-25-002822 · form4-02032025_080218.xml · derivative · entry 4

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,911

Underlying: Common Stock · 54,911 shares

Expires 2033-09-13

F5 · derivative.exercise_date: The shares subject to this option shall vest in 12 equal monthly installments measured four years after August 15, 2022.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Saint SeanDirector · President & CEO
GrantEmployee Stock Option (right to buy) · Derivative 494,198 $0.00 Strike: $5.10 $0.00
Disclosure

SEC source: 0001415889-25-002822 · form4-02032025_080218.xml · derivative · entry 3

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 494,198

Underlying: Common Stock · 494,198 shares

Expires 2033-09-13

F4 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after August 15, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Saint SeanDirector · President & CEO
GrantEmployee Stock Option (right to buy) · Derivative 83,268 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001415889-25-002822 · form4-02032025_080218.xml · derivative · entry 2

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,268

Underlying: Common Stock · 83,268 shares

Expires 2032-07-31

F3 · derivative.exercise_date: The shares subject to this option shall vest in 12 equal monthly installments measured four years after August 1, 2022.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Saint SeanDirector · President & CEO
GrantEmployee Stock Option (right to buy) · Derivative 749,445 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001415889-25-002822 · form4-02032025_080218.xml · derivative · entry 1

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 749,445

Underlying: Common Stock · 749,445 shares

Expires 2032-07-31

F1 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Lezack AdamDirector
GrantDirector Stock Option (right to buy) · Derivative 9,137 $0.00 Strike: $5.10 $0.00
Disclosure

SEC source: 0001415889-25-002820 · form4-02032025_080213.xml · derivative · entry 1

Lezack Adam · CIK 0002048466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,137

Underlying: Common Stock · 9,137 shares

Expires 2033-12-11

F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from December 12, 2023.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Mensinger MikeChief Product Officer
GrantEmployee Stock Option (right to buy) · Derivative 110,278 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001415889-25-002819 · form4-02032025_080211.xml · derivative · entry 9

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,278

Underlying: Common Stock · 110,278 shares

Expires 2025-01-28

F7 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

F6 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Mensinger MikeChief Product Officer
GrantEmployee Stock Option (right to buy) · Derivative 236,553 $0.00 Strike: $5.10 $0.00
Disclosure

SEC source: 0001415889-25-002819 · form4-02032025_080211.xml · derivative · entry 8

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,553

Underlying: Common Stock · 236,553 shares

Expires 2033-09-13

F5 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after August 1, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.

F6 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Mensinger MikeChief Product Officer
OtherClass B Common Stock Warrant (right to buy) · Derivative 10,575 $0.00 Strike: $0.02 $0.00
Disclosure

SEC source: 0001415889-25-002819 · form4-02032025_080211.xml · derivative · entry 7

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,575 shares

Expires 2033-08-27

F4 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this warrant was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Mensinger MikeChief Product Officer
ConversionClass B Common Stock Warrant (right to buy) · Derivative 10,575 $0.00 Strike: $0.02 $0.00
Disclosure

SEC source: 0001415889-25-002819 · form4-02032025_080211.xml · derivative · entry 6

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,575

Underlying: Common Stock · 10,575 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this warrant was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Mensinger MikeChief Product Officer
ConversionSeries D Preferred Stock · Derivative 15,107 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-002819 · form4-02032025_080211.xml · derivative · entry 5

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,107 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date.

F1 · price: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date.

F1 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Mensinger MikeChief Product Officer
PurchaseCommon Stock 33,350 $17.00 $566,950.00
Disclosure

SEC source: 0001415889-25-002819 · form4-02032025_080211.xml · nonDerivative · entry 4

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,019

F3 · kind: The shares were purchased in the Issuer's initial public offering.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Mensinger MikeChief Product Officer
SaleCommon Stock 13 $17.00 $221.00
Disclosure

SEC source: 0001415889-25-002819 · form4-02032025_080211.xml · nonDerivative · entry 3

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,669

F2 · kind: On January 31, 2025, the reporting person exercised a warrant to purchase 10,575 shares of Issuer's common stock for $0.02 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in withholding of 13 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 10,562 shares.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Mensinger MikeChief Product Officer
OtherCommon Stock 10,575 $0.02 $211.50
Disclosure

SEC source: 0001415889-25-002819 · form4-02032025_080211.xml · nonDerivative · entry 2

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,682

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Mensinger MikeChief Product Officer
ConversionCommon Stock 15,107 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-002819 · form4-02032025_080211.xml · nonDerivative · entry 1

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,107

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC GrantDirector Stock Option (right to buy) · Derivative 48,730 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001415889-25-002818 · form4-02032025_080208.xml · derivative · entry 3

Jones Christy · CIK 0002048467 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,730

Underlying: Common Stock · 48,730 shares

Expires 2032-07-26

F4 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from July 27, 2022.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC GrantDirector Stock Option (right to buy) · Derivative 9,137 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001415889-25-002818 · form4-02032025_080208.xml · derivative · entry 2

Jones Christy · CIK 0002048467 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,137

Underlying: Common Stock · 9,137 shares

Expires 2031-12-07

F3 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from July 20, 2021.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC GrantDirector Stock Option (right to buy) · Derivative 9,137 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001415889-25-002818 · form4-02032025_080208.xml · derivative · entry 1

Jones Christy · CIK 0002048467 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,137

Underlying: Common Stock · 9,137 shares

Expires 2031-12-07

F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from April 27, 2021.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Hopman MarkChief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 47,775 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001415889-25-002817 · form4-02032025_080206.xml · derivative · entry 5

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,775

Underlying: Common Stock · 47,775 shares

Expires 2035-01-28

F6 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Hopman MarkChief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 39,424 $0.00 Strike: $10.74 $0.00
Disclosure

SEC source: 0001415889-25-002817 · form4-02032025_080206.xml · derivative · entry 4

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,424

Underlying: Common Stock · 39,424 shares

Expires 2034-09-29

F5 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 30, 2024.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Hopman MarkChief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 17,765 $0.00 Strike: $8.51 $0.00
Disclosure

SEC source: 0001415889-25-002817 · form4-02032025_080206.xml · derivative · entry 3

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,765

Underlying: Common Stock · 17,765 shares

Expires 2033-12-31

F4 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from January 1, 2024.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Hopman MarkChief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 37,229 $0.00 Strike: $5.10 $0.00
Disclosure

SEC source: 0001415889-25-002817 · form4-02032025_080206.xml · derivative · entry 2

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,229

Underlying: Common Stock · 37,229 shares

Expires 2033-09-13

F3 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Hopman MarkChief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 83,242 $0.00 Strike: $5.10 $0.00
Disclosure

SEC source: 0001415889-25-002817 · form4-02032025_080206.xml · derivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,242

Underlying: Common Stock · 83,242 shares

Expires 2033-07-26

F1 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Feider StephenChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 186,203 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001415889-25-002816 · form4-02032025_080204.xml · derivative · entry 3

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,203

Underlying: Common Stock · 186,203 shares

Expires 2035-01-28

F4 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Feider StephenChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 109,695 $0.00 Strike: $5.10 $0.00
Disclosure

SEC source: 0001415889-25-002816 · form4-02032025_080204.xml · derivative · entry 2

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,695

Underlying: Common Stock · 109,695 shares

Expires 2033-09-13

F3 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
Feider StephenChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 166,542 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001415889-25-002816 · form4-02032025_080204.xml · derivative · entry 1

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,542

Underlying: Common Stock · 166,542 shares

Expires 2032-07-31

F1 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
CARNEY SEANDirector
GrantDirector Stock Option (right to buy) · Derivative 30,456 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001415889-25-002815 · form4-02032025_080201.xml · derivative · entry 2

CARNEY SEAN · CIK 0001239312 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,456

Underlying: Common Stock · 30,456 shares

Expires 2032-07-26

F3 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from July 27, 2022.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 01:30 UTC
CARNEY SEANDirector
GrantDirector Stock Option (right to buy) · Derivative 55,837 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001415889-25-002815 · form4-02032025_080201.xml · derivative · entry 1

CARNEY SEAN · CIK 0001239312 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,837

Underlying: Common Stock · 55,837 shares

Expires 2030-05-14

F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from February 12, 2020.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 21:34 UTC
Russell Steven JonChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 90,637 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001415889-25-002484 · form4-01312025_090101.xml · derivative · entry 1

Russell Steven Jon · CIK 0002051384 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,637

Underlying: Class B Common Stock · 90,637 shares

Expires 2035-01-28

F1 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 21:35 UTC
Saint SeanDirector · President & CEO
GrantEmployee Stock Option (right to buy) · Derivative 467,944 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001415889-25-002490 · form4-01312025_090147.xml · derivative · entry 1

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 467,944

Underlying: Class B Common Stock · 467,944 shares

Expires 2035-01-28

F1 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 21:32 UTC
Mensinger MikeChief Product Officer
GrantEmployee Stock Option (right to buy) · Derivative 110,278 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001415889-25-002481 · form4-01312025_090141.xml · derivative · entry 1

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,278

Underlying: Class B Common Stock · 110,278 shares

Expires 2035-01-28

F1 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 21:31 UTC
Hopman MarkChief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 47,775 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001415889-25-002480 · form4-01312025_090153.xml · derivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,775

Underlying: Class B Common Stock · 47,775 shares

Expires 2035-01-28

F1 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 21:30 UTC
Feider StephenChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 186,203 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001415889-25-002479 · form4-01312025_090132.xml · derivative · entry 1

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,203

Underlying: Class B Common Stock · 186,203 shares

Expires 2035-01-28

F1 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.